Beyond the Static MOA: How to Design AI‑Optimized Explainer Videos for Pharma
In a world where artificial intelligence shapes how content is discovered and recommended, the traditional static mechanism of action (MOA) video is quickly becoming...
FTC Pharma Promotion Rules in 2026: What Now Counts as “Advertising”?
In 2026, the landscape of pharmaceutical marketing is undergoing one of the most significant shifts in decades. The Federal Trade Commission’s (FTC) evolving interpretation...
The Invisible EHR: Why Clinical UX Is the Silent Driver of Pharma Engagement
Electronic Health Records (EHRs) are the backbone of modern clinical workflows, yet the user experience within EHR platforms often remains an overlooked factor in...
Informa Connect 2026 Events
Upcoming Informa Connect Events:
Speaker Programs Summit - March 2-4, 2026
Rare Disease Summit - March 17-19, 2026
PAP...
From Recap to Revenue: How to Turn 2026 Pharma Conferences into Campaign Gold
Conferences offer a rare chance for pharma marketers to gather cutting-edge insights from regulatory bodies, AI innovators, and ad-promo leaders. Yet too often, the...
FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do About It.
Digital health technologies are reshaping the future of patient care, but not in isolation. The FDA’s latest pilot programs, like TEMPO, are becoming testbeds...
India, LATAM, and the Quiet Rewiring of Global Pharma Marketing
Across the globe, global pharma marketing operations are being transformed in profound ways. India and Latin America (LATAM) stand...
Stop Hosting Webinars. Start Building HCP Learning Hubs.
Healthcare professionals (HCPs) are no longer satisfied with stand-alone webinars and temporary campaign microsites. As digital behaviors evolve, so do the expectations of HCPs....
Before Anyone Sees Your Ad, an Algorithm Does: Designing for AI-Triaged Media
Before your carefully crafted ad copy reaches a single healthcare provider, patient, or caregiver, it often passes through unseen gatekeepers: algorithms. Today, AI triage...
From Posts to Protocols: The New Rules for Patient Influencer Campaigns
As patient influencers face closer FDA and FTC scrutiny, pharma brands must evolve from one-off sponsored posts to safety-first, protocol-driven partnerships. This article explores...
